Literature DB >> 16242150

P66shc regulates endothelial NO production and endothelium-dependent vasorelaxation: implications for age-associated vascular dysfunction.

Tohru Yamamori1, Anthony R White, Ilwola Mattagajasingh, Firdous A Khanday, Azeb Haile, Bing Qi, Byeong Hwa Jeon, Artem Bugayenko, Kenji Kasuno, Dan E Berkowitz, Kaikobad Irani.   

Abstract

The p66shc adaptor protein mediates age-associated oxidative stress. We examined the role of p66shc in endothelial nitric oxide synthase (eNOS) signaling. Overexpression of p66shc inhibited eNOS-dependent NO production. RNAi-mediated down-regulation of endogenous p66shc led to activation of the proto-oncogene ras, and Akt kinase, with a corresponding increase in phosphorylation of eNOS at S1177 (S1179 on bovine eNOS). In rat aortic rings, down-regulation of p66shc suppressed the vasoconstrictor response to phenyephrine that was abrogated by treatment with the NOS inhibitor l-NAME, and enhanced vasodilation induced by sub-maximal doses of acetylcholine. These findings highlight a pivotal role for p66shc in inhibiting endothelial NO production, and endothelium-dependent vasorelaxation, that may provide important mechanistic information about endothelial dysfunction seen with aging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242150     DOI: 10.1016/j.yjmcc.2005.09.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  26 in total

1.  Epigenetic upregulation of p66shc mediates low-density lipoprotein cholesterol-induced endothelial cell dysfunction.

Authors:  Young-Rae Kim; Cuk-Seong Kim; Asma Naqvi; Ajay Kumar; Santosh Kumar; Timothy A Hoffman; Kaikobad Irani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

2.  Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc.

Authors:  Cuk-Seong Kim; Young-Rae Kim; Asma Naqvi; Santosh Kumar; Timothy A Hoffman; Saet-Byel Jung; Ajay Kumar; Byeong-Hwa Jeon; Dennis M McNamara; Kaikobad Irani
Journal:  Cardiovasc Res       Date:  2011-09-20       Impact factor: 10.787

Review 3.  Mechanisms of vascular aging: new perspectives.

Authors:  Zoltan Ungvari; Gabor Kaley; Rafael de Cabo; William E Sonntag; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-24       Impact factor: 6.053

Review 4.  Effects of aging on angiogenesis.

Authors:  Johanna Lähteenvuo; Anthony Rosenzweig
Journal:  Circ Res       Date:  2012-04-27       Impact factor: 17.367

5.  The expression of p66shc in peripheral blood monocytes is increased in patients with coronary heart disease and correlated with endothelium-dependent vasodilatation.

Authors:  Qin Miao; Qiong Wang; Lini Dong; Yanjiao Wang; Yi Tan; Xiangyu Zhang
Journal:  Heart Vessels       Date:  2014-03-28       Impact factor: 2.037

6.  Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction.

Authors:  Santosh Kumar; Young-Rae Kim; Ajit Vikram; Asma Naqvi; Qiuxia Li; Modar Kassan; Vikas Kumar; Markus M Bachschmid; Julia S Jacobs; Ajay Kumar; Kaikobad Irani
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 7.  Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.

Authors:  Emanuele Marzetti; Anna Csiszar; Debapriya Dutta; Gauthami Balagopal; Riccardo Calvani; Christiaan Leeuwenburgh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-07       Impact factor: 4.733

8.  Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc.

Authors:  Ajay Kumar; Timothy A Hoffman; Jeremy Dericco; Asma Naqvi; Mukesh K Jain; Kaikobad Irani
Journal:  FASEB J       Date:  2009-08-20       Impact factor: 5.191

9.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-07-07

Review 10.  New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.

Authors:  Fabio Di Lisa; Marco Giorgio; Peter Ferdinandy; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-04-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.